Clinical Trial Update: Safety and Efficacy of Intratympanic Application of Dexamethasone Via Catheter in Patients With Sudden Hearing Loss [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of intratympanic dexamethasone delivered via catheter for sudden sensorineural hearing loss; the study has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sudden Sensorineural Hearing Loss

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Sudden Deafness | Phase 3 | Status: COMPLETED